# Percutaneous Edge To Edge Repair for the Treatment of Severe Tricuspid Valve Regurgitation in High-surgical Risk Patients With Systemic Right Ventricle : a Multicentric French Cohort (PETER-TRESRIV)

> **NCT05052177** · — · UNKNOWN · sponsor: **University of Bordeaux** · enrollment: 10 (estimated)

## Conditions studied

- Systemic Right Ventricle
- Tricuspid Regurgitation
- Congenital Heart Disease

## Interventions

- **DEVICE:** Edge to edge repair in systemic tricuspid valve regurgitation

## Key facts

- **NCT ID:** NCT05052177
- **Lead sponsor:** University of Bordeaux
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-01
- **Primary completion:** 2022-10-30
- **Final completion:** 2022-10-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2021-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05052177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05052177, "Percutaneous Edge To Edge Repair for the Treatment of Severe Tricuspid Valve Regurgitation in High-surgical Risk Patients With Systemic Right Ventricle : a Multicentric French Cohort (PETER-TRESRIV)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05052177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*